CD4 and COVID-19: Analyzing CD4+ T cells that are reactive against the spike glycoprotein of SARS-CoV-2 in the peripheral blood, Braun et al. detected spike-reactive CD4+ T cells not only in 83% of patients with COVID-19 but also in 35% of SARS-CoV-2-unexposed healthy donors.